1 1299 113 DECREASED REELIN EXPRESSION IN THE LEFT PREFRONTAL CORTEX (BA9) IN CHRONIC SCHIZOPHRENIA PATIENTS. BACKGROUND: REELIN IS UNDER EPIGENETIC CONTROL AND HAS BEEN REPORTED TO BE DECREASED IN CORTICAL REGIONS IN SCHIZOPHRENIA. METHODS: TO ESTABLISH IF EXPRESSION OF REELIN IS ALTERED IN SPECIFIC CORTICAL, HIPPOCAMPAL OR THALAMIC REGIONS OF SCHIZOPHRENIA PATIENTS, WE MEASURED GENE EXPRESSION OF REELIN IN A POSTMORTEM STUDY OF ELDERLY PATIENTS WITH SCHIZOPHRENIA AND NON-AFFECTED CONTROLS IN BOTH HEMISPHERES DIFFERENTIATING BETWEEN GRAY AND WHITE MATTER. WE COMPARED CEREBRAL POSTMORTEM SAMPLES (DORSOLATERAL PREFRONTAL CORTEX BA9 AND BA46, SUPERIOR TEMPORAL CORTEX BA22, ENTORHINAL CORTEX BA28, SENSORIC CORTEX BA1-3, HIPPOCAMPUS, CA4, MEDIODORSAL NUCLEUS OF THE THALAMUS) FROM 12 SCHIZOPHRENIA PATIENTS WITH 13 NORMAL SUBJECTS INVESTIGATING GENE EXPRESSION OF REELIN IN THE GRAY AND WHITE MATTER OF BOTH HEMISPHERES BY IN SITU-HYBRIDIZATION. RESULTS: THE LEFT PREFRONTAL AREA (BA9) OF SCHIZOPHRENIA PATIENTS REVEALED A DECREASED EXPRESSION OF REELIN-MRNA OF 29.1% IN THE WHITE (P = 0.022) AND 13.6% IN THE GRAY MATTER (P = 0.007) COMPARED TO THE CONTROL GROUP. NONE OF THE OTHER REGIONS EXAMINED SHOWED ANY STATISTICALLY SIGNIFICANT DIFFERENCES. CONCLUSION: SINCE REELIN IS RESPONSIBLE FOR MIGRATION AND SYNAPSE FORMATION, THE DECREASED GENE EXPRESSION OF REELIN IN THE LEFT PREFRONTAL AREA OF SCHIZOPHRENIA PATIENTS POINTS TO NEURODEVELOPMENTAL DEFICITS IN NEURONAL MIGRATION AND SYNAPTIC PLASTICITY. HOWEVER, OUR STUDY GROUP WAS SMALL, AND RESULTS SHOULD BE VERIFIED USING LARGER SAMPLES. 2012 2 5273 35 PROMOTER METHYLATION AND BDNF AND DAT1 GENE EXPRESSION PROFILES IN PATIENTS WITH DRUG ADDICTION. BACKGROUND: DRUG ADDICTION IS A BRAIN DISORDER THAT HAS NEGATIVE CONSEQUENCES FOR INDIVIDUALS AND SOCIETY. ADDICTIONS ARE CHRONIC RELAPSING DISEASES OF THE BRAIN THAT ARE CAUSED BY DIRECT DRUG-INDUCED EFFECTS AND PERSEVERING NEUROADAPTATIONS AT THE EPIGENETIC, NEUROPEPTIDE AND NEUROTRANSMITTER LEVELS. BECAUSE THE DOPAMINERGIC SYSTEM HAS A SIGNIFICANT ROLE IN DRUG ABUSE, THE PURPOSE OF THIS STUDY WAS TO ANALYZE THE METHYLATION AND EXPRESSION PROFILE OF BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) AND DOPAMINE TRANSPORTER (DAT1) GENES IN INDIVIDUALS WITH DRUG ADDICTION. MATERIALS AND METHODS: BDNF AND DAT1 PROMOTER METHYLATION WERE INVESTIGATED WITH A METHYLATION-SPECIFIC POLYMERASE CHAIN REACTION (PCR) TECHNIQUE IN BLOOD SAMPLES FROM 75 INDIVIDUALS WITH DRUG ADDICTION AND 65 HEALTHY CONTROLS. THE EXPRESSION LEVELS OF BDNF AND DAT1 WERE ASSESSED IN 12 MRNA SAMPLES FROM THE BLOOD OF PATIENTS AND COMPARED TO THE SAMPLES OF HEALTHY CONTROLS (N = 12) WITH REAL-TIME QUANTITATIVE REVERSE TRANSCRIPTION PCR. RESULTS: NO SIGNIFICANT DIFFERENCES WERE FOUND IN THE METHYLATION OF BDNF AND DAT1 BETWEEN PATIENTS AND CONTROLS, BUT THE RELATIVE LEVELS OF EXPRESSION OF BDNF AND DAT1 MRNA DIFFERED SIGNIFICANTLY IN THE PATIENTS COMPARED TO CONTROLS (P < 0.0001). CONCLUSION: THESE RESULTS SHOWED THAT THE METHYLATION STATUS OF THE BDNF AND DAT1 GENES HAD NO SIGNIFICANT FUNCTION IN THE PROCESSES OF DRUG ADDICTION. 2015 3 5205 26 PRENATAL STRESS CHANGES THE GLYCOPROTEIN GPM6A GENE EXPRESSION AND INDUCES EPIGENETIC CHANGES IN RAT OFFSPRING BRAIN. PRENATAL STRESS (PS) EXERTS STRONG IMPACT ON FETAL BRAIN DEVELOPMENT AND ON ADULT OFFSPRING BRAIN FUNCTIONS. PREVIOUS WORK DEMONSTRATED THAT CHRONIC STRESS ALTERS THE MRNA EXPRESSION OF GPM6A, A NEURONAL GLYCOPROTEIN INVOLVED IN FILOPODIUM EXTENSION. IN THIS WORK, WE ANALYZED THE EFFECT OF PS ON GPM6A EXPRESSION AND THE EPIGENETIC MECHANISMS INVOLVED. PREGNANT WISTAR RATS RECEIVED RESTRAINT STRESS DURING THE LAST WEEK OF GESTATION. MALE OFFSPRING WERE SACRIFICED ON POSTNATAL DAYS 28 AND 60. HIPPOCAMPUS AND PREFRONTAL CORTEX SAMPLES WERE ANALYZED FOR GENE EXPRESSION (QPCR FOR MRNAS AND MICRORNAS), METHYLATION STATUS (BISULFITE CONVERSION) AND PROTEIN LEVELS. HIPPOCAMPAL NEURONS IN CULTURE WERE USED TO ANALYZE MICRORNA OVEREXPRESSION EFFECTS. PRENATAL STRESS INDUCED CHANGES IN GPM6A LEVELS IN BOTH TISSUES AND AT BOTH AGES ANALYZED, INDICATING A PERSISTENT EFFECT. TWO CPG ISLANDS IN THE GPM6A GENE WERE IDENTIFIED. VARIATIONS IN THE METHYLATION PATTERN AT THREE SPECIFIC CPGS WERE FOUND IN HIPPOCAMPUS, BUT NOT IN PFC SAMPLES FROM PS OFFSPRING. MICRORNAS PREDICTED TO TARGET GPM6A WERE IDENTIFIED IN SILICO. QPCR MEASUREMENTS SHOWED THAT PS MODIFIED THE EXPRESSION OF SEVERAL MICRORNAS IN BOTH TISSUES, BEING MICRORNA-133B THE MOST SIGNIFICANTLY ALTERED. FURTHER STUDIES OVEREXPRESSING THIS MICRORNA IN NEURONAL CULTURES SHOWED A REDUCTION IN GMP6A MRNA AND PROTEIN LEVEL. MOREOVER FILOPODIUM DENSITY WAS ALSO REDUCED, SUGGESTING THAT GPM6A FUNCTION WAS AFFECTED. GESTATIONAL STRESS AFFECTED GPM6A GENE EXPRESSION IN OFFSPRING LIKELY THROUGH CHANGES IN METHYLATION STATUS AND IN POSTTRANSCRIPTIONAL REGULATION BY MICRORNAS. THUS, OUR FINDINGS PROPOSE GPM6A AS A NOVEL TARGET FOR EPIGENETIC REGULATION DURING PRENATAL STRESS. 2014 4 433 32 ANTIDEPRESSANT TREATMENT IS ASSOCIATED WITH EPIGENETIC ALTERATIONS OF HOMER1 PROMOTER IN A MOUSE MODEL OF CHRONIC DEPRESSION. BACKGROUND: UNDERSTANDING THE NEUROBIOLOGY OF DEPRESSION AND THE MECHANISM OF ACTION OF THERAPEUTIC MEASURES IS CURRENTLY A RESEARCH PRIORITY. WE HAVE SHOWN THAT THE EXPRESSION OF THE SYNAPTIC PROTEIN HOMER1A CORRELATES WITH DEPRESSION-LIKE BEHAVIOR AND ITS INDUCTION IS A COMMON MECHANISM OF ACTION OF DIFFERENT ANTIDEPRESSANT TREATMENTS. HOWEVER, THE MECHANISM OF HOMER1A REGULATION IS STILL UNKNOWN. METHODS: WE COMBINED THE CHRONIC DESPAIR MOUSE MODEL (CDM) OF CHRONIC DEPRESSION WITH DIFFERENT ANTIDEPRESSANT TREATMENTS. DEPRESSION-LIKE BEHAVIOR WAS CHARACTERIZED BY FORCED SWIM AND TAIL SUSPENSION TESTS, AND VIA AUTOMATIC MEASUREMENT OF SUCROSE PREFERENCE IN INTELLICAGE. THE HOMER1 MRNA EXPRESSION AND PROMOTER DNA METHYLATION WERE ANALYZED IN CORTEX AND PERIPHERAL BLOOD BY QRT-PCR AND PYROSEQUENCING. RESULTS: CDM MICE SHOW DECREASED HOMER1A AND HOMER1B/C MRNA EXPRESSION IN CORTEX AND BLOOD SAMPLES, WHILE CHRONIC TREATMENT WITH IMIPRAMINE AND FLUOXETINE OR ACUTE KETAMINE APPLICATION INCREASES THEIR LEVEL ONLY IN THE CORTEX. THE QUANTITATIVE ANALYSES OF THE METHYLATION OF 7 CPG SITES, LOCATED ON THE HOMER1 PROMOTER REGION CONTAINING SEVERAL CRE BINDING SITES, SHOW A SIGNIFICANT INCREASE IN DNA METHYLATION IN THE CORTEX OF CDM MICE. IN CONTRAST, ANTIDEPRESSANT TREATMENTS REDUCE THE METHYLATION LEVEL. LIMITATIONS: HOMER1 EXPRESSION AND PROMOTOR METHYLATION WERE NOT ANALYZED IN DIFFERENT BLOOD CELL TYPES. OTHER CPG SITES OF HOMER1 PROMOTER SHOULD BE INVESTIGATED IN FUTURE STUDIES. OUR EXPERIMENTAL APPROACH DOES NOT DISTINGUISH BETWEEN METHYLATION AND HYDROXYMETHYLATION. CONCLUSIONS: WE DEMONSTRATE THAT STRESS-INDUCED DEPRESSION-LIKE BEHAVIOR AND ANTIDEPRESSANT TREATMENTS ARE ASSOCIATED WITH EPIGENETIC ALTERATIONS OF HOMER1 PROMOTER, PROVIDING NEW INSIGHTS INTO THE MECHANISM OF ANTIDEPRESSANT TREATMENT. 2021 5 3133 23 GLOBAL DNA HYPOMETHYLATION AND ITS CORRELATION TO THE BETAINE LEVEL IN PERIPHERAL BLOOD OF PATIENTS WITH SCHIZOPHRENIA. ACCUMULATING EVIDENCE SUGGESTS THAT ABERRANT EPIGENETIC REGULATION IS INVOLVED IN THE PATHOPHYSIOLOGY OF MAJOR PSYCHIATRIC DISORDERS SUCH AS SCHIZOPHRENIA (SZ) AND BIPOLAR DISORDER (BD). WE PREVIOUSLY SHOWED THAT THE PLASMA LEVEL OF BETAINE (N,N,N-TRIMETHYLGLYCINE), A METHYL-GROUP DONOR, WAS SIGNIFICANTLY DECREASED IN PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA (FESZ). IN THIS STUDY, WE IDENTIFIED DECREASE OF GLOBAL DNA METHYLATION LEVEL IN FESZ (N = 24 PATIENTS VS N = 42 CONTROLS), AND FOUND THAT GLOBAL DNA METHYLATION LEVEL WAS INVERSELY CORRELATED WITH SCORES ON THE GLOBAL ASSESSMENT OF FUNCTIONING (GAF) SCALE, AND POSITIVELY CORRELATED WITH PLASMA BETAINE LEVEL. NOTABLY, CORRELATIONS BETWEEN LEVELS OF BETAINE AND ITS METABOLITES (N,N-DIMETHYLGLYCINE AND SARCOSINE, N-METHYLGLYCINE) WERE LOWER OR LOST IN FESZ PLASMA, BUT REMAINED HIGH IN CONTROLS. WE FURTHER EXAMINED GLOBAL DNA METHYLATION LEVELS IN PATIENTS WITH CHRONIC SZ (N = 388) AND BD (N = 414) AS WELL AS CONTROLS (N = 430), AND CONFIRMED SIGNIFICANT HYPOMETHYLATION AND DECREASED BETAINE LEVEL IN SZ. WE ALSO FOUND THAT PATIENTS WITH BD TYPE I, BUT NOT THOSE WITH BD TYPE II, SHOWED SIGNIFICANT GLOBAL HYPOMETHYLATION. THESE RESULTS SUGGEST THAT GLOBAL HYPOMETHYLATION ASSOCIATED WITH DECREASED BETAINE LEVEL IN BLOOD CELLS IS COMMON TO SZ AND BD, AND MAY REFLECT COMMON PATHOPHYSIOLOGY SUCH AS PSYCHOTIC SYMPTOMS. 2020 6 6156 21 THE GENETIC INFLUENCE ON THE CORTICAL PROCESSING OF EXPERIMENTAL PAIN AND THE MODERATING EFFECT OF PAIN STATUS. BACKGROUND: RESEARCH SUGGESTS THAT THE COMT VAL(158)MET, BDNF VAL(66)MET AND OPRM1 A(118)G POLYMORPHISMS MODERATE THE EXPERIENCE OF PAIN. IN ORDER TO OBTAIN EXPERIMENTAL CONFIRMATION AND EXTENSION OF FINDINGS, CORTICAL PROCESSING OF EXPERIMENTALLY-INDUCED PAIN WAS USED. METHOD: A SAMPLE OF 78 INDIVIDUALS WITH CHRONIC LOW BACK PAIN COMPLAINTS AND 37 HEALTHY CONTROLS UNDERWENT EEG REGISTRATION. EVENT-RELATED POTENTIALS WERE MEASURED IN RESPONSE TO ELECTRICAL NOCICEPTIVE STIMULI AND MODERATION BY COMT VAL(158)MET, BDNF VAL(66)MET AND OPRM1 A(118)G POLYMORPHISMS WAS ASSESSED. RESULTS: GENETIC VARIATION DID NOT HAVE A DIRECT EFFECT ON CORTICAL PROCESSING OF EXPERIMENTAL PAIN. HOWEVER, GENETIC EFFECTS (COMT VAL(158)MET AND BDNF VAL(66)MET) ON EXPERIMENTAL PAIN WERE MODERATED BY THE PRESENCE OF CHRONIC PAIN. IN THE PRESENCE OF CHRONIC PAIN, THE COMT MET ALLELE AND THE BDNF MET ALLELE AUGMENTED CORTICAL PAIN PROCESSING, WHILST REDUCING PAIN PROCESSING IN PAIN-FREE CONTROLS. NO SIGNIFICANT EFFECTS WERE FOUND CONCERNING THE OPRM1 A(118)G POLYMORPHISM. CONCLUSIONS: THE CURRENT STUDY SUGGESTS THAT CHRONIC EXPERIENCE OF PAIN ENHANCES GENETIC SENSITIVITY TO EXPERIMENTALLY INDUCED MILDLY PAINFUL STIMULI, POSSIBLY THROUGH A PROCESS OF EPIGENETIC MODIFICATION. 2010 7 3650 35 INCREASED TRANSCRIPTION OF TSPO, HDAC2, AND HDAC6 IN THE AMYGDALA OF MALES WITH ALCOHOL USE DISORDER. INTRODUCTION: REPEATED EXPOSURE TO HIGH DOSES OF ALCOHOL TRIGGERS NEUROINFLAMMATORY PROCESSES THAT CONTRIBUTE TO CRAVING AND MOOD DYSFUNCTION IN ALCOHOL USE DISORDER (AUD). THE UPREGULATION OF THE TRANSLOCATOR PROTEIN (TSPO) IS CONSIDERED A BIOMARKER OF NEUROINFLAMMATION, AND TSPO LIGANDS HAVE BEEN USED AS NEUROIMAGING BIOMARKERS OF NEUROINFLAMMATION. EPIGENETIC MECHANISMS ARE ALSO IMPLICATED IN NEUROINFLAMMATORY RESPONSES TO ALCOHOL, AND ELEVATED EXPRESSION OF HDAC2 AND HDAC6 HAS BEEN REPORTED IN THE BRAIN OF ANIMALS EXPOSED TO CHRONIC ALCOHOL. METHODS: THE PRESENT STUDY EXAMINED THE TRANSCRIPTIONAL REGULATION OF TSPO, HDAC2, AND HDAC6 IN HUMAN POSTMORTEM BRAIN TISSUE FROM MALES PREVIOUSLY DIAGNOSED WITH AUD (N = 11) COMPARED TO AGE-MATCHED NONDEPENDENT MALES (N = 13) IN FOUR BRAIN REGIONS RELEVANT TO AUD: PREFRONTAL CORTEX (PFC), NUCLEUS ACCUMBENS (NAC), HIPPOCAMPUS (HPP), AND AMYGDALA (AMY). RESULTS: TRANSLOCATOR PROTEIN MRNA LEVELS IN AMY AND PFC AND HDAC2 AND HDAC6 MRNA LEVELS IN AMY WERE UPREGULATED IN AUD COMPARED TO CONTROLS. IN AMY, TSPO MRNA LEVELS WERE POSITIVELY ASSOCIATED WITH HDAC2 AND HDAC6 MRNA LEVELS, SUGGESTING A POSSIBLE REGULATION OF TSPO BY HDAC2 AND HDAC6 IN THIS BRAIN REGION. IN CONTRAST, THERE WERE NO GROUP DIFFERENCES FOR TSPO, HDAC2, AND HDAC6 IN NAC AND HPP. CONCLUSION: OUR STUDY IS THE FIRST TO FIND UPREGULATED TSPO MRNA LEVELS IN AMY AND PFC IN POSTMORTEM BRAINS FROM AUD CONSISTENT WITH NEUROINFLAMMATION, AND IN THE AMYGDALA, THEY IMPLICATE EPIGENETIC REGULATION OF TSPO BY HDAC2 AND HDAC6. 2021 8 1328 29 DEPRESSION AND STRESS LEVELS INCREASE RISK OF LIVER CANCER THROUGH EPIGENETIC DOWNREGULATION OF HYPOCRETIN. RECENT STUDIES SUGGEST THAT HYPOCRETIN (HCRT, OREXIN) ARE INVOLVED IN STRESS REGULATION OF DEPRESSION THROUGH THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS. HOWEVER, THE MOLECULAR MECHANISM BY WHICH HYPOCRETIN REGULATE NEUROBIOLOGICAL RESPONSES IS UNKNOWN. HEREIN, THE EFFECTS OF CHRONIC STRESS ON THE EPIGENETIC MODIFICATION OF HCRT AND ITS ASSOCIATION WITH DEPRESSION WERE EXPLORED WITH REGARD TO A POTENTIAL ROLE IN CANCER PROGRESSION. IN THE STUDY, SPRAGUE DAWLEY (SD) RATS WERE USED TO ESTABLISH AN ANIMAL MODEL OF CANCER WITH DEPRESSION BY ADMINISTRATING N-NITROSODIETHYLAMINE (DEN) AND CHRONIC UNPREDICTABLE MILD STRESS (CUMS). RNA-SEQUENCING WAS USED TO DETECT DIFFERENTIALLY EXPRESSED GENES IN THE HIPPOCAMPUS OF RATS AND QUANTITATIVE REAL-TIME POLYMERASE CHAIN REACTION (QRT-PCR) WAS USED TO VALIDATE THE RESULTS OF RNA-SEQUENCING. THE STATUS OF HCRT PROMOTER METHYLATION WAS ASSESSED BY METHYLATION SPECIFIC POLYMERASE CHAIN REACTION. BEHAVIORAL TESTS SHOWED THAT RATS EXPOSED TO CUMS HAD SIGNIFICANT DEPRESSIVE-LIKE BEHAVIORS. THE NUMBER OF LIVER TUMORS AND TUMOR LOAD IN DEPRESSED RATS EXPOSED TO CUMS WAS HIGHER THAN IN SD RATS WITHOUT CUMS. RNA-SEQUENCING REVEALED THAT HCRT WAS ONE OF THE MOST SIGINIFICANTLY DOWNREGULATED GENE IN THE HIPPOCAMPUS OF SD RATS WITH CUMS COMPARED TO NON-STRESSED GROUP, WHICH WAS VALIDATED BY QRT-PCR. HCRT MRNA EXPRESSION WAS DOWNREGULATED AND THE PROMOTER FOR HCRT WAS HYPER-METHYLATED IN THOSE WITH DEPRESSION. THESE RESULTS IDENTIFIED A CRITICAL ROLE FOR CHRONIC PSYCHOLOGICAL STRESSORS IN TUMORIGENESIS AND CANCER PROGRESSION, VIA EPIGENETIC HCRT DOWNREGULATION. SUCH EPIGENETIC DOWNREGULATION MAY BE THE MOLECULAR BASIS FOR THE ASSOCIATION OF CANCER WITH DEPRESSION. 2022 9 1671 27 DRD2 METHYLATION IS ASSOCIATED WITH EXECUTIVE CONTROL NETWORK CONNECTIVITY AND SEVERITY OF ALCOHOL PROBLEMS AMONG A SAMPLE OF POLYSUBSTANCE USERS. CHRONIC EXPOSURE TO ALCOHOL AND OTHER DRUGS OF ABUSE HAS BEEN ASSOCIATED WITH DELETERIOUS CONSEQUENCES, INCLUDING FUNCTIONAL CONNECTIVITY DEFICITS WITHIN NEURAL NETWORKS ASSOCIATED WITH EXECUTIVE CONTROL. ALTERED FUNCTIONAL CONNECTIVITY WITHIN THE EXECUTIVE CONTROL NETWORK (ECN) MIGHT UNDERLIE THE PROGRESSIVE INABILITY TO CONTROL CONSUMPTION OF ALCOHOL AND OTHER DRUGS AS SUBSTANCE USE DISORDERS PROGRESS. GENETIC AND EPIGENETIC FACTORS HAVE BEEN ASSOCIATED WITH SUBSTANCE USE DISORDERS (SUDS). FOR EXAMPLE, DOPAMINE RECEPTOR 2 (DRD2) FUNCTIONING HAS BEEN ASSOCIATED WITH ALCOHOL USE DISORDER (AUD) AND RELATED PHENOTYPES, INCLUDING CORRELATES OF EXECUTIVE FUNCTIONING. THE PRESENT STUDY AIMS TO EXPLORE THE RELATIONSHIP BETWEEN A CONTINUOUS MEASURE OF ALCOHOL-RELATED PROBLEMS, EPIGENETIC MARKERS (METHYLATION) WITHIN THE DRD2 GENE, AND FUNCTIONAL CONNECTIVITY WITHIN THE ECN AMONG A SAMPLE OF POLYSUBSTANCE USERS. A COMMUNITY SAMPLE OF 658 SUBJECTS, WHOSE CONSUMPTION OF ALCOHOL, NICOTINE, AND CANNABIS SPAN ACROSS A SPECTRUM OF QUANTITY AND FREQUENCY OF USE, WERE OBTAINED ACROSS PREVIOUS STUDIES IN POLYSUBSTANCE USING POPULATIONS. RESTING STATE FUNCTIONAL MAGNETIC RESONANCE IMAGING WAS ANALYZED TO IDENTIFY INTRINSIC CONNECTIVITY NETWORKS USING A PRIORI REGIONS OF INTEREST. METHYLATION MEASUREMENT OF FUNCTIONALLY RELEVANT SITES WITHIN THE DRD2 GENE WAS ACHIEVED VIA PYROSEQUENCING. REGRESSION-BASED MODELS, INCLUDING MEDIATION AND MODERATION MODELS, TESTED THE ASSOCIATION BETWEEN DRD2 METHYLATION, FUNCTIONAL CONNECTIVITY WITHIN INTRINSIC NEURAL NETWORKS (INCLUDING THE ECN), AND SEVERITY OF ALCOHOL PROBLEMS. RESULTS SUGGEST THAT AVERAGE DRD2 METHYLATION WAS NEGATIVELY ASSOCIATED WITH RIGHT ECN (RECN) AND LEFT ECN (LECN) CONNECTIVITY, BUT NOT ASSOCIATED WITH OTHER NETWORKS TESTED, AND DRD2 METHYLATION WAS SIGNIFICANTLY ASSOCIATED WITH ALCOHOL PROBLEMS SEVERITY. MEDIATION MODELS WERE NOT SUPPORTED, ALTHOUGH MODERATION MODELS SUGGESTED THAT CONNECTIVITY BETWEEN EDGES WITHIN THE RECN MODERATED THE RELATIONSHIP BETWEEN DRD2 METHYLATION AND AUD SEVERITY. RESULTS SUPPORT A THEORETICAL MODEL IN WHICH EPIGENETIC FACTORS ARE ASSOCIATED WITH NEUROBIOLOGICAL CORRELATES OF ALCOHOL CONSUMPTION AMONG A SAMPLE OF POLYSUBSTANCE USERS. 2020 10 2967 34 GENETIC AND EPIGENETIC REGULATION OF CATECHOL-O-METHYLTRANSFERASE IN RELATION TO INFLAMMATION IN CHRONIC FATIGUE SYNDROME AND FIBROMYALGIA. BACKGROUND: CATECHOL-O-METHYLTRANSFERASE (COMT) HAS BEEN SHOWN TO INFLUENCE CLINICAL PAIN, DESCENDING MODULATION, AND EXERCISE-INDUCED SYMPTOM WORSENING. COMT REGULATES NOCICEPTIVE PROCESSING AND INFLAMMATION, KEY PATHOPHYSIOLOGICAL FEATURES OF CHRONIC FATIGUE SYNDROME AND FIBROMYALGIA (CFS/FM). WE AIMED TO DETERMINE THE INTERACTIONS BETWEEN GENETIC AND EPIGENETIC MECHANISMS REGULATING COMT AND ITS INFLUENCE ON INFLAMMATORY MARKERS AND SYMPTOMS IN PATIENTS WITH CFS/FM. METHODS: A CASE-CONTROL STUDY WITH REPEATED-MEASURES DESIGN WAS USED TO REDUCE THE CHANCE OF FALSE POSITIVE AND INCREASE THE POWER OF OUR FINDINGS. FIFTY-FOUR PARTICIPANTS (28 PATIENTS WITH CFS/FM AND 26 CONTROLS) WERE ASSESSED TWICE WITHIN 4 DAYS. THE ASSESSMENT INCLUDED CLINICAL QUESTIONNAIRES, NEUROPHYSIOLOGICAL ASSESSMENT (PAIN THRESHOLDS, TEMPORAL SUMMATION, AND CONDITIONED PAIN MODULATION), AND BLOOD WITHDRAWAL IN ORDER TO ASSESS RS4818, RS4633, AND RS4680 COMT POLYMORPHISMS AND PERFORM HAPLOTYPE ESTIMATION, DNA METHYLATION IN THE COMT GENE (BOTH MB-COMT AND S-COMT PROMOTERS), AND CYTOKINE EXPRESSION (TNF-ALPHA, IFN-GAMMA, IL-6, AND TGF-BETA). RESULTS: COMT HAPLOTYPES WERE ASSOCIATED WITH DNA METHYLATION IN THE S-COMT PROMOTER, TGF-BETA EXPRESSION, AND SYMPTOMS. HOWEVER, THIS WAS NOT SPECIFIC FOR ONE CONDITION. SIGNIFICANT BETWEEN-GROUP DIFFERENCES WERE FOUND FOR INCREASED DNA METHYLATION IN THE MB-COMT PROMOTER AND DECREASED IFN-GAMMA EXPRESSION IN PATIENTS. DISCUSSION: OUR RESULTS ARE CONSISTENT WITH BASIC AND CLINICAL RESEARCH, PROVIDING INTERESTING INSIGHTS INTO GENETIC-EPIGENETIC REGULATORY MECHANISMS. MB-COMT DNA METHYLATION MIGHT BE AN INDEPENDENT FACTOR CONTRIBUTING TO THE PATHOPHYSIOLOGY OF CFS/FM. FURTHER RESEARCH ON DNA METHYLATION IN COMPLEX CONDITIONS SUCH AS CFS/FM IS WARRANTED. WE RECOMMEND FUTURE RESEARCH TO EMPLOY A REPEATED-MEASURE DESIGN TO CONTROL FOR BIOMARKERS VARIABILITY AND WITHIN-SUBJECT CHANGES. 2022 11 2319 32 EPIGENETIC REGULATION OF GABAERGIC NEUROTRANSMISSION AND NEUROSTEROID BIOSYNTHESIS IN ALCOHOL USE DISORDER. BACKGROUND: ALCOHOL USE DISORDER (AUD) IS A CHRONIC RELAPSING BRAIN DISORDER. GABAA RECEPTOR (GABAAR) SUBUNITS ARE A TARGET FOR THE PHARMACOLOGICAL EFFECTS OF ALCOHOL. NEUROSTEROIDS PLAY AN IMPORTANT ROLE IN THE FINE-TUNING OF GABAAR FUNCTION IN THE BRAIN. RECENTLY, WE HAVE SHOWN THAT AUD IS ASSOCIATED WITH CHANGES IN DNA METHYLATION MECHANISMS. HOWEVER, THE ROLE OF DNA METHYLATION IN THE REGULATION OF NEUROSTEROID BIOSYNTHESIS AND GABAERGIC NEUROTRANSMISSION IN AUD PATIENTS REMAINS UNDER-INVESTIGATED. METHODS: IN A COHORT OF POSTMORTEM BRAINS FROM 20 MALE CONTROLS AND AUD PATIENTS, WE INVESTIGATED THE EXPRESSION OF GABAAR SUBUNITS AND NEUROSTEROID BIOSYNTHETIC ENZYMES AND THEIR REGULATION BY DNA METHYLATION MECHANISMS. NEUROSTEROID LEVELS WERE QUANTIFIED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY. RESULTS: THE ALPHA 2 SUBUNIT EXPRESSION WAS REDUCED DUE TO INCREASED DNA METHYLATION AT THE GENE PROMOTER REGION IN THE CEREBELLUM OF AUD PATIENTS, A BRAIN AREA PARTICULARLY SENSITIVE TO THE EFFECTS OF ALCOHOL. ALCOHOL-INDUCED ALTERATION IN GABAAR SUBUNITS WAS ALSO OBSERVED IN THE PREFRONTAL CORTEX. NEUROSTEROID BIOSYNTHESIS WAS ALSO AFFECTED WITH REDUCED CEREBELLAR EXPRESSION OF THE 18KDA TRANSLOCATOR PROTEIN AND 3ALPHA-HYDROXYSTEROID DEHYDROGENASE MRNAS. NOTABLY, INCREASED DNA METHYLATION LEVELS WERE OBSERVED AT THE PROMOTER REGION OF 3ALPHA-HYDROXYSTEROID DEHYDROGENASE. THESE CHANGES WERE ASSOCIATED WITH MARKEDLY REDUCED LEVELS OF ALLOPREGNANOLONE AND PREGNANOLONE IN THE CEREBELLUM. CONCLUSION: GIVEN THE KEY ROLE OF NEUROSTEROIDS IN MODULATING THE STRENGTH OF GABAAR-MEDIATED INHIBITION, OUR DATA SUGGEST THAT ALCOHOL-INDUCED IMPAIRMENTS IN GABAERGIC NEUROTRANSMISSION MIGHT BE PROFOUNDLY IMPACTED BY REDUCED NEUROSTEROID BIOSYNTHESIS MOST LIKELY VIA DNA HYPERMETHYLATION. 2021 12 3986 26 LONG-TERM OVARIECTOMY INCREASES BDNF GENE METHYLATION STATUS IN MOUSE HIPPOCAMPUS. ESTRADIOL (E) HAS BEEN SUGGESTED TO HAVE A NEUROPROTECTIVE EFFECT IN YOUNG ANIMALS BUT HAS NEUTRAL OR HARMFUL EFFECTS WHEN IT IS ADMINISTERED TO AGED ANIMALS. IN THE PRESENT STUDY, WE DETERMINED WHETHER THE POST-OVARIECTOMY (POST-OVX) TIMEFRAME ELAPSED BEFORE THE INITIATION OF CHRONIC E TREATMENT IS CRITICAL FOR THE ESTROGENIC INDUCTION OF NEUROTROPHINS (BRAIN-DERIVED NEUROTROPHIC FACTOR, BDNF, AND SYNAPTOPHYSIN, SYN) IN THE RODENT HIPPOCAMPUS. ADULT MICE WERE OVX AND, A SHORT PERIOD (SHORT-TERM E (STE) ANIMALS) OR A LONG PERIOD (LONG-TERM E (LTE) ANIMALS) AFTER THE OVX, WERE DAILY TREATED WITH E. CONTROL ANIMALS WERE TREATED WITH SESAME OIL (SHORT-TERM CONTROL (STC) AND LONG-TERM CONTROL (LTC) ANIMALS). PROTEIN EXPRESSION WAS DETERMINED USING AN IMMUNOHISTOCHEMICAL APPROACH. TRANSCRIPTIONAL ACTIVITY IN THE HIPPOCAMPUS OF INDIVIDUAL BDNF PROMOTERS WAS ASSESSED BY REAL-TIME QUANTITATIVE RT-PCR, AND THE METHYLATION LEVELS OF REGULATORY REGIONS WERE ANALYZED BY METHYLATION-SPECIFIC PCR AND COMBINED BISULFITE RESTRICTION ANALYSIS. STE ANIMALS SHOWED INCREASED BDNF AND SYN PROTEIN EXPRESSION AND A HIGHER ACTIVITY OF BDNF II, IV, AND V PROMOTERS. IN CONTRAST, LTE ANIMALS DID NOT SHOW E INDUCTION OF NEUROTROPHINS. IN THESE ANIMALS, THE METHYLATION LEVELS OF REGULATORY SEQUENCES OF THE BDNF WERE HIGHER THAN IN THE STE ANIMALS IN A CPG ISLAND OF PROMOTER V AND IN THE CRE REGULATORY SITE LOCATED IN PROMOTER IV. WITH THIS EXPERIMENT, WE DETERMINED THAT A PROLONGED PERIOD OF HYPOESTROGENICITY DISRUPTS THE E-INDUCTION OF NEUROTROPHINS, AND WE POSTULATED THAT DNA METHYLATION IS ONE OF THE EPIGENETIC MECHANISMS THAT COULD EXPLAIN THE E-INSENSITIVITY OF THE BDNF AFTER A LONG PERIOD POST-OVX. 2014 13 6411 31 THE SITE SPECIFIC DEMETHYLATION IN THE 5'-REGULATORY AREA OF NMDA RECEPTOR 2B SUBUNIT GENE ASSOCIATED WITH CIE-INDUCED UP-REGULATION OF TRANSCRIPTION. BACKGROUND: THE NMDA RECEPTOR REPRESENTS A PARTICULARLY IMPORTANT SITE OF ETHANOL ACTION IN THE CNS. WE RECENTLY REPORTED THAT NMDA RECEPTOR 2B (NR2B) GENE EXPRESSION WAS PERSISTENTLY UP-REGULATED FOLLOWING CHRONIC INTERMITTENT ETHANOL (CIE) TREATMENT. INCREASING EVIDENCE THAT EPIGENETIC MECHANISMS ARE INVOLVED IN DYNAMIC AND LONG-LASTING REGULATION OF GENE EXPRESSION IN MULTIPLE NEUROADAPTIVE PROCESSES PROMPTED US TO INVESTIGATE THE ROLE OF DNA METHYLATION IN MEDIATING CIE-INDUCED UP-REGULATION OF NR2B GENE TRANSCRIPTION. TO DISSECT THE CHANGES OF DNA METHYLATION IN THE NR2B GENE, WE HAVE SCREENED A LARGE NUMBER OF CPG SITES WITHIN ITS 5'-REGULATORY AREA FOLLOWING CIE TREATMENT. METHODS: PRIMARY CORTICAL CULTURED NEURONS WERE SUBJECTED TO ETHANOL TREATMENT IN A CIE PARADIGM. BISULFITE CONVERSION FOLLOWED BY PYROSEQUENCING WAS USED FOR QUANTITATIVE MEASUREMENT AND ANALYSIS OF CPG METHYLATION STATUS WITHIN THE 5'-REGULATORY AREA OF THE NR2B GENE; CHROMATIN IMMUNOPRECIPITATION (CHIP) ASSAY WAS USED TO EXAMINE DNA LEVELS ASSOCIATED WITH METHYLATION AND TRANSCRIPTION FACTOR BINDING. ELECTROPHORETIC MOBILITY SHIFT ASSAY (EMSA) AND IN VITRO DNA METHYLATION ASSAYS WERE PERFORMED TO DETERMINE THE DIRECT IMPACT OF DNA METHYLATION ON THE INTERACTION BETWEEN DNA AND TRANSCRIPTION FACTOR AND PROMOTER ACTIVITY. RESULTS: ANALYSIS OF INDIVIDUAL CPG METHYLATION SITES WITHIN THE NR2B 5'REGULATORY AREA REVEALED THREE REGIONS WITH CLUSTERS OF SITE-SPECIFIC CPG DEMETHYLATION FOLLOWING CIE TREATMENT AND WITHDRAWAL. THIS WAS CONFIRMED BY CHIP SHOWING SIMILAR DECREASES OF METHYLATED DNA IN THE SAME REGIONS. THE CIE-INDUCED DEMETHYLATION IS CHARACTERIZED BY BEING LOCATED NEAR CERTAIN TRANSCRIPTION FACTOR BINDING SEQUENCES, AP-1 AND CRE, AND OCCURRED DURING TREATMENT AS WELL AS AFTER ETHANOL WITHDRAWAL. FURTHERMORE, THE INCREASE IN VITRO OF METHYLATED DNA DECREASED TRANSCRIPTION FACTOR BINDING ACTIVITY AND PROMOTER ACTIVITY. AN ADDITIONAL CHIP ASSAY INDICATED THAT THE CIE-INDUCED DNA DEMETHYLATION IS ACCOMPANIED BY INCREASED OCCUPATION BY TRANSCRIPTION FACTORS. CONCLUSIONS: THESE RESULTS SUGGEST AN IMPORTANT ROLE OF DNA DEMETHYLATION IN MEDIATING CIE-INDUCED NR2B GENE UP-REGULATION, THUS IMPLICATING A NOVEL MOLECULAR SITE OF ALCOHOL ACTION. 2010 14 5065 28 PHOTOPERIOD-INDUCED NEUROTRANSMITTER PLASTICITY DECLINES WITH AGING: AN EPIGENETIC REGULATION? NEUROPLASTICITY HAS CLASSICALLY BEEN UNDERSTOOD TO ARISE THROUGH CHANGES IN SYNAPTIC STRENGTH OR SYNAPTIC CONNECTIVITY. A NEWLY DISCOVERED FORM OF NEUROPLASTICITY, NEUROTRANSMITTER SWITCHING, INVOLVES CHANGES IN NEUROTRANSMITTER IDENTITY. CHRONIC EXPOSURE TO DIFFERENT PHOTOPERIODS ALTERS THE NUMBER OF DOPAMINE (TYROSINE HYDROXYLASE, TH+) AND SOMATOSTATIN (SST+) NEURONS IN THE PARAVENTRICULAR NUCLEUS (PAVN) OF THE HYPOTHALAMUS OF ADULT RATS AND RESULTS IN DISCRETE BEHAVIORAL CHANGES. HERE, WE INVESTIGATE WHETHER PHOTOPERIOD-INDUCED NEUROTRANSMITTER SWITCHING PERSISTS DURING AGING AND WHETHER EPIGENETIC MECHANISMS OF HISTONE ACETYLATION AND DNA METHYLATION MAY CONTRIBUTE TO THIS NEUROTRANSMITTER PLASTICITY. WE SHOW THAT THIS PLASTICITY IN RATS IS ROBUST AT 1 AND AT 3 MONTHS BUT REDUCED IN TH+ NEURONS AT 12 MONTHS AND COMPLETELY ABOLISHED IN BOTH TH+ AND SST+ NEURONS BY 18 MONTHS. DE NOVO EXPRESSION OF DNMT3A CATALYZING DNA METHYLATION AND ANTI-ACETYLH3 ASSESSING HISTONE 3 ACETYLATION WERE OBSERVED FOLLOWING SHORT-DAY PHOTOPERIOD EXPOSURE IN BOTH TH+ AND SST+ NEURONS AT 1 AND 3 MONTHS WHILE AN OVERALL INCREASE IN DNMT3A IN SST+ NEURONS PARALLELED NEUROPLASTICITY REDUCTION AT 12 AND 18 MONTHS. HISTONE ACETYLATION INCREASED IN TH+ NEURONS AND DECREASED IN SST+ NEURONS FOLLOWING SHORT-DAY EXPOSURE AT 3 MONTHS WHILE THE TOTAL NUMBER OF ANTI-ACETYLH3+ PAVN NEURONS REMAINED CONSTANT. RECIPROCAL HISTONE ACETYLATION IN TH+ AND SST+ NEURONS INDICATES THE IMPORTANCE OF STUDYING EPIGENETIC REGULATION AT THE CIRCUIT LEVEL FOR IDENTIFIED CELL PHENOTYPES. THE FINDINGS MAY BE USEFUL FOR DEVELOPING APPROACHES FOR NONINVASIVE TREATMENT OF DISORDERS CHARACTERIZED BY NEUROTRANSMITTER DYSFUNCTION. 2020 15 1554 32 DNA METHYLATION LEVELS OF RELN PROMOTER REGION IN ULTRA-HIGH RISK, FIRST EPISODE AND CHRONIC SCHIZOPHRENIA COHORTS OF SCHIZOPHRENIA. THE ESSENTIAL ROLE OF THE REELIN GENE (RELN) DURING BRAIN DEVELOPMENT MAKES IT A PROMINENT CANDIDATE IN HUMAN EPIGENETIC STUDIES OF SCHIZOPHRENIA. PREVIOUS LITERATURE HAS REPORTED DIFFERING LEVELS OF DNA METHYLATION (DNAM) IN PATIENTS WITH PSYCHOSIS. THEREFORE, THIS STUDY AIMED TO (1) EXAMINE AND COMPARE RELN DNAM LEVELS IN SUBJECTS AT DIFFERENT STAGES OF PSYCHOSIS CROSS-SECTIONALLY, (2) ANALYSE THE EFFECT OF ANTIPSYCHOTICS (AP) ON DNAM, AND (3) EVALUATE THE EFFECTIVENESS AND APPLICABILITY OF RELN PROMOTER DNAM AS A POSSIBLE BIOLOGICAL-BASED MARKER FOR SYMPTOM SEVERITY IN PSYCHOSIS.. THE STUDY COHORT CONSISTED OF 56 HEALTHY CONTROLS, 87 ULTRA-HIGH RISK (UHR) INDIVIDUALS, 26 FIRST-EPISODE (FE) PSYCHOSIS INDIVIDUALS AND 30 CHRONIC SCHIZOPHRENIA (CS) INDIVIDUALS. THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) WAS USED TO ASSESS SCHIZOPHRENIA SEVERITY. AFTER PYROSEQUENCING SELECTED CPG SITES OF PERIPHERAL BLOOD, THE AVERAGE MEAN DNAM LEVELS WERE COMPARED AMONGST THE 4 SUBGROUPS. OUR RESULTS SHOWED DIFFERING LEVELS OF DNAM, WITH UHR HAVING THE LOWEST (7.72 +/- 0.19) WHILE THE CS HAD THE HIGHEST LEVELS (HC: 8.78 +/- 0.35; FE: 7.75 +/- 0.37; CS: 8.82 +/- 0.48). SIGNIFICANTLY HIGHER AVERAGE MEAN DNAM LEVELS WERE FOUND IN CS SUBJECTS ON AP (9.12 +/- 0.61) COMPARED TO UHR WITHOUT MEDICATION (UHR(-)) (7.39 +/- 0.18). A SIGNIFICANT ASSOCIATION WAS ALSO OBSERVED BETWEEN THE AVERAGE MEAN DNAM OF FE AND PANSS NEGATIVE SYMPTOM FACTOR (R(2) = 0.237, SS = -0.401, *P = 0.033). IN CONCLUSION, OUR FINDINGS SUGGESTED DIFFERENT LEVELS OF DNAM FOR SUBJECTS AT DIFFERENT STAGES OF PSYCHOSIS. THOSE SUBJECTS THAT TOOK AP HAVE DIFFERENT DNAM LEVELS. THERE WERE SIGNIFICANT ASSOCIATIONS BETWEEN FE DNAM AND NEGATIVE PANSS SCORES. WITH MORE FUTURE EXPERIMENTS AND ON LARGER COHORTS, THERE MAY BE POTENTIAL USE OF DNAM OF THE RELN GENE AS ONE OF THE GENES FOR THE BIOLOGICAL-BASED MARKER FOR SYMPTOM SEVERITY IN PSYCHOSIS. 2022 16 5339 23 QUETIAPINE TREATMENT REVERSES DEPRESSIVE-LIKE BEHAVIOR AND REDUCES DNA METHYLTRANSFERASE ACTIVITY INDUCED BY MATERNAL DEPRIVATION. STRESS IN EARLY LIFE HAS BEEN APPOINTED AS AN IMPORTANT PHENOMENON IN THE ONSET OF DEPRESSION AND POOR RESPONSE TO TREATMENT WITH CLASSICAL ANTIDEPRESSANTS. FURTHERMORE, CHILDHOOD TRAUMA TRIGGERS EPIGENETIC CHANGES, WHICH ARE ASSOCIATED WITH THE PATHOPHYSIOLOGY OF MAJOR DEPRESSIVE DISORDER (MDD). TREATMENT WITH ATYPICAL ANTIPSYCHOTICS SUCH AS QUETIAPINE, EXERTS THERAPEUTIC EFFECT FOR MDD PATIENTS AND INDUCES EPIGENETIC CHANGES. THIS STUDY AIMED TO ANALYZE THE EFFECT OF CHRONIC TREATMENT WITH QUETIAPINE (20MG/KG) ON DEPRESSIVE-LIKE BEHAVIOR OF RATS SUBMITTED TO MATERNAL DEPRIVATION (MD), AS WELL AS THE ACTIVITY OF HISTONE ACETYLATION BY THE ENZYMES HISTONE ACETYL TRANSFERASES (HAT) AND DEACETYLASES (HDAC) AND DNA METHYLATION, THROUGH DNA METHYLTRANSFERASE ENZYME (DNMT) IN THE PREFRONTAL CORTEX (PFC), NUCLEUS ACCUMBENS (NAC) AND HIPPOCAMPUS. MATERNALLY DEPRIVED RATS HAD A DEPRESSIVE-LIKE BEHAVIOR IN THE FORCED SWIMMING TEST AND AN INCREASE IN THE HDAC AND DNMT ACTIVITIES IN THE HIPPOCAMPUS AND NAC. TREATMENT WITH QUETIAPINE REVERSED DEPRESSIVE-LIKE BEHAVIOR AND REDUCED THE DNMT ACTIVITY IN THE HIPPOCAMPUS. THIS IS THE FIRST STUDY TO SHOW THE ANTIDEPRESSANT-LIKE EFFECT OF QUETIAPINE IN ANIMALS SUBJECTED TO MD AND A PROTECTIVE EFFECT BY QUETIAPINE IN REDUCING EPIGENETIC CHANGES INDUCED BY STRESS IN EARLY LIFE. THESE RESULTS REINFORCE AN IMPORTANT ROLE OF QUETIAPINE AS THERAPY FOR MDD. 2017 17 1820 27 EFFECTS OF CHRONIC RESTRAINT STRESS ON THE GLOBAL DNA METHYLATION PROFILE OF RAT LUNG CELLS: MODULATION BY PHYSICAL EXERCISE. THE POTENTIAL OF BEHAVIORAL STRESS TO AFFECT EPIGENETIC MECHANISMS OF NON-ENCEPHALIC TISSUES IS STILL UNDERESTIMATED. IN THE PRESENT STUDY WE EVALUATED THE EFFECTS OF CHRONIC BEHAVIORAL STRESS ON THE DNA METHYLATION PROFILE OF RAT LUNG CELLS. FURTHERMORE, WE EVALUATED THE POTENTIAL OF PHYSICAL EXERCISE TO MODULATE THE CHANGES EVOKED BY BEHAVIORAL STRESS IN LUNG CELLS. MALE WISTAR RATS WERE DIVIDED INTO FOUR EXPERIMENTAL GROUPS: (1) ANIMALS SUBMITTED TO CHRONIC RESTRAINT STRESS (CRS) (ST GROUP) DURING THE PERIOD OF THE 67TH-80TH POSTNATAL DAY (PND); (2) ANIMALS SUBMITTED TO PHYSICAL EXERCISE (EX GROUP) DURING THE 53RD-79TH PND; (3) ANIMALS SUBMITTED TO SWIMMING DURING THE 53RD-79TH PND AND TO CRS DURING THE 67TH-80TH PND (EX-ST GROUP); AND (4) ANIMALS NOT SUBMITTED TO STRESS OR SWIMMING PROTOCOLS (CTL). GLOBAL DNA METHYLATION WAS QUANTIFIED USING AN ELISA-BASED APPROACH AND GENE EXPRESSION WAS EVALUATED BY REAL TIME PCR. A DECREASED GLOBAL DNA METHYLATION PROFILE WAS OBSERVED IN THE ST GROUP, HOWEVER PHYSICAL EXERCISE DEMONSTRATED PROTECTION OF LUNG CELLS FROM THIS STRESS-RELATED HYPOMETHYLATION. INCREASED EXPRESSION OF THE DNMT1 GENE WAS EVIDENCED IN THE ST GROUP, WHEREAS PHYSICAL EXERCISE WAS SHOWN TO PROTECT LUNG CELLS FROM THIS STRESS-RELATED EFFECT IN THE EX-ST GROUP. COMPARATIVE ANALYSIS OF THE ST AND EX GROUPS REVEALED OPPOSITE EFFECTS ON THE EXPRESSION OF DNMT3A AND DNMT3B; HOWEVER, A STRESS-RELATED INCREASE IN EXPRESSION OF DNMT3A AND DNMT3B WAS NOT SEEN IN THE EX-ST GROUP. OUR DATA SHOWED THAT BEHAVIORAL STRESS INDUCED SIGNIFICANT CHANGES IN THE DNA METHYLATION PROFILE OF RAT LUNG CELLS AND THAT THIS COULD BE MODULATED BY PHYSICAL EXERCISE. 2017 18 2035 28 EPIGENETIC CHANGES OF FKBP5 AS A LINK CONNECTING GENETIC AND ENVIRONMENTAL RISK FACTORS WITH STRUCTURAL AND FUNCTIONAL BRAIN CHANGES IN MAJOR DEPRESSION. THE GENE FOR THE GLUCOCORTICOID RECEPTOR REGULATOR FK506 BINDING PROTEIN 5 (FKBP5) PLAYS A ROLE FOR RISK, RESPONSE TO TREATMENT, AND CHANGES IN BRAIN AREAS IN MAJOR DEPRESSIVE DISORDER (MDD). CHRONIC STRESS IS ASSOCIATED WITH LOWER METHYLATION OF FKBP5. OUR AIM WAS TO INVESTIGATE WHETHER METHYLATION OF FKBP5 REFLECTED EXPOSURE TO CHILDHOOD ADVERSITY IN MDD AND CONTROLS AND WHETHER IT WAS ASSOCIATED WITH STRUCTURE AND FUNCTION OF EMOTIONAL PROCESSING REGIONS. FKBP5 INTRON 7 GR RESPONSE ELEMENT REGION METHYLATION AND RS1360780 ALLELIC STATUS WERE ASSESSED FROM WHOLE BLOOD IN 56 MDD ADULTS AND 50 CONTROLS. USING MAGNETIC RESONANCE IMAGING, WE ASSESSED GRAY MATTER CONCENTRATION OF SELECTED AREAS AND THEIR FUNCTION DURING VALENCE RECOGNITION OF EMOTIONAL IMAGES. CHILDHOOD ADVERSITY WAS INVESTIGATED USING THE CHILDHOOD TRAUMA QUESTIONNAIRE. IN MDD PATIENTS CARRYING THE HIGH-RISK T ALLELE OF RS1360780, LOWER METHYLATION OF FKBP5 WAS PREDICTED BY CHILDHOOD ADVERSITY (F=4.95, P=0.04). IN ALL PARTICIPANTS, LOWER FKBP5 INTRON METHYLATION LEVELS WERE ASSOCIATED WITH REDUCED GRAY MATTER CONCENTRATION IN THE INFERIOR FRONTAL ORBITAL GYRUS BILATERALLY (WALD CHI-SQUARE=11.93, P(FDR)<0.01) AND, IN MDD, WITH ITS BILATERALLY HIGHER ACTIVATION DURING VALENCE RECOGNITION (WALD CHI-SQUARE=5.58, P=0.02). ACTIVATION OF THIS REGION, REGARDLESS OF SIDE, WAS FOUND TO BE LOWER IN MDD COMPARED TO CONTROLS (WALD CHI-SQUARE=3.88, P=0.049) AND TO BE INVERSELY CORRELATED WITH DEPRESSION SEVERITY (WALD CHI-SQUARE=4.65, P=0.03). OUR FINDINGS SUPPORT THE HYPOTHESIS THAT, IN GENETICALLY PREDISPOSED INDIVIDUALS CARRYING A HIGH-RISK VARIANT OF THE GENE, CHILDHOOD MALTREATMENT MIGHT INDUCE DEMETHYLATION OF FKBP5. THIS IS IN TURN ASSOCIATED WITH STRUCTURAL AND FUNCTIONAL CHANGES IN THE INFERIOR FRONTAL ORBITAL GYRUS, A RELEVANT AREA FOR THE CLINICAL SYMPTOMS OF MDD. 2018 19 3905 34 LEPTIN PROMOTER METHYLATION IN FEMALE PATIENTS WITH PAINFUL MULTISOMATOFORM DISORDER AND CHRONIC WIDESPREAD PAIN. BACKGROUND: DIFFERENT FUNCTIONAL SOMATIC SYNDROMES (FSS), FIBROMYALGIA (FMS) AND OTHER UNEXPLAINED PAINFUL CONDITIONS SHARE MANY COMMON CLINICAL TRAITS AND ARE CHARACTERIZED BY TROUBLING AND FUNCTIONALLY DISABLING SOMATIC SYMPTOMS. CHRONIC PAIN IS MOST FREQUENTLY REPORTED AND AT THE CENTER OF PATIENTS' LEVEL OF DISEASE BURDEN. THE CONSTRUCT OF MULTISOMATOFORM DISORDER (MSD) ALLOWS TO SUBSUME SEVERELY IMPAIRED PATIENTS SUFFERING FROM FSS, FMS AND OTHER UNEXPLAINED PAINFUL CONDITIONS TO BE EXAMINED FOR COMMON UNDERLYING PROCESSES. ALTERED LEPTIN LEVELS AND A PATHOLOGICAL RESPONSE OF THE HPA-AXIS AS A RESULT OF CHRONIC STRESS AND CHILDHOOD TRAUMA HAVE BEEN SUGGESTED AS ONE OF THE DRIVING FACTORS OF DISEASE DEVELOPMENT AND SEVERITY. PREVIOUS STUDIES HAVE DEMONSTRATED THAT METHYLATION OF THE LEPTIN PROMOTER CAN PLAY A REGULATORY ROLE IN ADDICTION. IN THIS STUDY, WE HYPOTHESIZED THAT METHYLATION OF THE LEPTIN PROMOTER IS INFLUENCED BY THE DEGREE OF CHILDHOOD TRAUMATIZATION AND DIFFERS BETWEEN PATIENTS WITH MSD AND CONTROLS. A COHORT OF 151 PATIENTS WITH MSD AND 149 MATCHED HEALTHY VOLUNTEERS WERE EVALUATED USING CLINICAL AND PSYCHOMETRIC ASSESSMENT WHILE METHYLATION LEVEL ANALYSIS OF THE LEPTIN PROMOTER WAS PERFORMED USING DNA ISOLATED FROM WHOLE BLOOD. RESULTS: IN FEMALE CONTROLS, WE FOUND CPG C-167 TO BE NEGATIVELY CORRELATED WITH LEPTIN LEVELS, WHEREAS IN FEMALE PATIENTS CPG C-289, C-255, C-193, C-167 AND METHYLATION CLUSTER (C-291 TO C-167) AT PUTATIVE BINDINGS SITES FOR TRANSCRIPTION FACTORS SP1 AND C/EBPALPHA WERE NEGATIVELY CORRELATED WITH LEPTIN LEVELS. METHYLATION LEVELS WERE SIGNIFICANTLY LOWER IN FEMALE PATIENTS CPG C-289 COMPARED WITH CONTROLS. WHEN LOOKING AT FEMALE PATIENTS WITH CHRONIC WIDESPREAD PAIN METHYLATION LEVELS WERE SIGNIFICANTLY LOWER AT CPG C-289, C-255 AND METHYLATION CLUSTER (C-291 TO C-167). CONCLUSION: OUR FINDINGS SUPPORT THE HYPOTHESIS THAT EPIGENETIC REGULATION OF LEPTIN PLAYS A ROLE IN THE REGULATION OF LEPTIN LEVELS IN PATIENTS WITH MSD. THIS EFFECT IS MORE PRONOUNCED IN PATIENTS WITH CHRONIC WIDESPREAD PAIN. 2022 20 905 23 CHRONIC EXPOSURE TO CANNABINOIDS DURING ADOLESCENCE CAUSES LONG-LASTING BEHAVIORAL DEFICITS IN ADULT MICE. REGULAR USE OF MARIJUANA DURING ADOLESCENCE ENHANCES THE RISK OF LONG-LASTING NEUROBIOLOGICAL CHANGES IN ADULTHOOD. THE PRESENT STUDY WAS AIMED AT ASSESSING THE EFFECT OF LONG-TERM ADMINISTRATION OF THE SYNTHETIC CANNABINOID WIN55212.2 DURING ADOLESCENCE IN YOUNG ADULT MICE. ADOLESCENT MICE AGED 5 WEEKS WERE SUBJECTED DAILY TO THE PHARMACOLOGICAL ACTION OF WIN55212.2 FOR 3 WEEKS AND WERE THEN LEFT UNDISTURBED IN THEIR HOME CAGE FOR A 5-WEEK PERIOD AND FINALLY EVALUATED BY BEHAVIORAL TESTING. MICE THAT RECEIVED THE DRUG DURING ADOLESCENCE SHOWED MEMORY IMPAIRMENT IN THE MORRIS WATER MAZE, AS WELL AS A DOSE-DEPENDENT MEMORY IMPAIRMENT IN FEAR CONDITIONING. IN ADDITION, THE ADMINISTRATION OF 3 MG/KG WIN55212.2 IN ADOLESCENCE INCREASED ADULT HIPPOCAMPAL AEA LEVELS AND PROMOTED DNA HYPERMETHYLATION AT THE INTRAGENIC REGION OF THE INTRACELLULAR SIGNALING MODULATOR RGS7, WHICH WAS ACCOMPANIED BY A LOWER RATE OF MRNA TRANSCRIPTION OF THIS GENE, SUGGESTING A POTENTIAL CAUSAL RELATION. ALTHOUGH THE CONCRETE MECHANISMS UNDERLYING THE BEHAVIORAL OBSERVATIONS REMAIN TO BE ELUCIDATED, WE DEMONSTRATE THAT LONG-TERM ADMINISTRATION OF 3 MG/KG OF WIN DURING ADOLESCENCE LEADS TO INCREASED ENDOCANNABINOID LEVELS AND ALTERED RGS7 EXPRESSION IN ADULTHOOD AND ESTABLISH A POTENTIAL LINK TO EPIGENETIC CHANGES. 2017